Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study.
Adinolfi LE, Petta S, Fracanzani AL, Nevola R, Coppola C, Narciso V, Rinaldi L, Calvaruso V, Pafundi PC, Lombardi R, Staiano L, Di Marco V, Solano A, Marrone A, Saturnino M, Rini F, Guerrera B, Troina G, Giordano M, Craxì A, Sasso FC. Adinolfi LE, et al. Among authors: guerrera b. Diabetes Obes Metab. 2020 Dec;22(12):2408-2416. doi: 10.1111/dom.14168. Epub 2020 Sep 6. Diabetes Obes Metab. 2020. PMID: 32761721
Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience.
Rinaldi L, Guarino M, Perrella A, Pafundi PC, Valente G, Fontanella L, Nevola R, Guerrera B, Iuliano N, Imparato M, Trabucco A, Sasso FC, Morisco F, Ascione A, Piai G, Adinolfi LE. Rinaldi L, et al. Among authors: guerrera b. Dig Dis Sci. 2019 Oct;64(10):3013-3019. doi: 10.1007/s10620-019-05604-8. Epub 2019 Apr 1. Dig Dis Sci. 2019. PMID: 30937719
Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study.
Rinaldi L, Perrella A, Guarino M, De Luca M, Piai G, Coppola N, Pafundi PC, Ciardiello F, Fasano M, Martinelli E, Valente G, Nevola R, Monari C, Miglioresi L, Guerrera B, Berretta M, Sasso FC, Morisco F, Izzi A, Adinolfi LE. Rinaldi L, et al. Among authors: guerrera b. J Transl Med. 2019 Aug 28;17(1):292. doi: 10.1186/s12967-019-2033-x. J Transl Med. 2019. PMID: 31462268 Free PMC article.
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study.
Adinolfi LE, Petta S, Fracanzani AL, Coppola C, Narciso V, Nevola R, Rinaldi L, Calvaruso V, Staiano L, Di Marco V, Marrone A, Pafundi PC, Solano A, Lombardi R, Sasso FC, Saturnino M, Rini F, Guerrera B, Troina G, Giordano M, Craxì A. Adinolfi LE, et al. Among authors: guerrera b. Atherosclerosis. 2020 Mar;296:40-47. doi: 10.1016/j.atherosclerosis.2020.01.010. Epub 2020 Jan 21. Atherosclerosis. 2020. PMID: 32005004 Clinical Trial.
Chronic HCV infection is a risk factor of ischemic stroke.
Adinolfi LE, Restivo L, Guerrera B, Sellitto A, Ciervo A, Iuliano N, Rinaldi L, Santoro A, Li Vigni G, Marrone A. Adinolfi LE, et al. Among authors: guerrera b. Atherosclerosis. 2013 Nov;231(1):22-6. doi: 10.1016/j.atherosclerosis.2013.08.003. Epub 2013 Aug 15. Atherosclerosis. 2013. PMID: 24125405
Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress.
Zampino R, Marrone A, Rinaldi L, Guerrera B, Nevola R, Boemio A, Iuliano N, Giordano M, Passariello N, Sasso FC, Albano E, Adinolfi LE. Zampino R, et al. Among authors: guerrera b. Infection. 2018 Dec;46(6):793-799. doi: 10.1007/s15010-018-1185-6. Epub 2018 Jul 31. Infection. 2018. PMID: 30066228
22 results